July 2017

Over the past 3 years, there has been a growing chorus of complaint about the rising costs of medications, particularly in oncology.

There is a lack of hard data on practice performance that makes it difficult to understand where to make improvements so that goals under the OCM can be reached.

Cancer Care Northwest made a successful bet on going fully independent and became a dominant provider in its market.

CMS has put so much emphasis on reported data that it is now paramount for oncology practices to understand how data should be sifted and interpreted to arrive at meaningful conclusions.

Practices in CMS’ Oncology Care Model are individually receiving hundreds of thousands of dollars in new annual revenue, but physicians and administrators are not exactly celebrating the influx of cash.